₹ 0.54
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Shree Ganesh Biotech (India) Ltd. functions as a biotechnology enterprise, concentrating its efforts on the development, preparation, and sale of hybrid seeds. Its catalog of products features rice seeds, plants grown through tissue culture, potato seeds, and various other agricultural items. The company was established on September 2, 1982, and maintains its principal office in Kolkata, India.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITD.
Data is available to registered users only